Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients
Intraoperative radiotherapy for brain tumours
ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib
Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population
Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs
Insights into germline genetic screening of breast cancer patients
Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC
Study shows association between tumour KIM-1 gene (HAVCR1) expression and immune infiltrates in RCC
Determinants of cancer disparities - Data driven insights from South East Asia
Bladder cancer updates from the second half of 2024
Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions
Relationship between governance and cervical cancer control